2023 ESC Guidelines for the management of acute coronary syndromes Page 1 2023 ESC
Guidelines for the management of acute coronary syndromes Developed by the task force on …

Cardiogenic shock (CS) is a heterogeneous syndrome reflecting a broad spectrum of shock
severity, diverse etiologies, variable cardiac function, different hemodynamic trajectories …

Background It is currently unclear if active left ventricular (LV) unloading should be used as
a primary treatment strategy or as a bailout in patients with cardiogenic shock (CS) treated …

Aims Early risk stratification is essential to guide treatment in cardiogenic shock (CS).
Existing CS risk scores were derived in selected cohorts, without accounting for the …

Aims Despite its high incidence and mortality risk, there is no evidence‐based treatment for
non‐ischaemic cardiogenic shock (CS). The aim of this study was to evaluate the use of …

Aims This study aimed to give contemporary insight into the use of Impella and venoarterial
extracorporeal membrane oxygenation (VA‐ECMO) in acute myocardial infarction‐related …

Background The benefits of standardized care for cardiogenic shock (CS) across regional
care networks are poorly understood. Objectives The authors compared the management …

Background Acute myocardial infarction complicated by cardiogenic shock (AMI‐CS) is
associated with significant morbidity and mortality. Mechanical circulatory support (MCS) …

Introduction Cardiogenic shock (CS) is a life-threatening condition and mechanical
circulatory support (MCS) might exert a relevant impact on its clinical course. Among MCS …

Background Observational and trial data have revealed significant improvement in
cardiogenic shock (CS) mortality due to acute myocardial infarction (AMI) after introducing …